Around the World - Health and nutrition claims for infant formula: international cross sectional survey
USA
Feb 20, 2023
Objectives To review available health and nutrition claims for infant formula products in multiple countries and to evaluate the validity of the evidence used for substantiation of claims.
Design International cross sectional survey.
Setting Public facing and healthcare professional facing company owned or company managed formula industry websites providing information about products marketed for healthy infants delivered at full term in 15 countries: Australia, Canada, Germany, India, Italy, Japan, Nigeria, Norway, Pakistan, Russia, Saudi Arabia, South Africa, Spain, the United Kingdom, and the United States in 2020-22.
Conclusions Most infant formula products had at least one health and nutrition claim. Multiple ingredients were claimed to achieve similar health or nutrition effects, multiple claims were made for the same ingredient type, most products did not provide scientific references to support claims, and referenced claims were not supported by robust clinical trial evidence.
Nigeria/USA - Navigating regulatory challenges and safety considerations in lactation supplement development: A Nigeria and US Comparison
Nigeria
Apr 17, 2024
USA - A new era for food in health? The FDA announces a qualified health claim for yogurt intake and type II diabetes mellitus risk reduction
USA
Apr 16, 2024
Amended maximum levels for the sum of 3-MCPD and 3-MCPD fatty acid esters in infant foods
European Union
Apr 08, 2024
BFSA publishes draft regulation on food advertising and claims
Bangladesh
Mar 18, 2024
FSSAI revises Standards for Children's Nutritional Foods
India
Mar 14, 2024
FDA endorses Qualified Health Claim for Yogurt and Reduced Risk of Type 2 Diabetes Mellitus
USA
Mar 07, 2024
USA - Food-Derived Bioactive Components and Health ClaimsThe Role of Regulatory Agencies
USA
Mar 04, 2024
New enforcement measure for health and nutrition claims regulation
UK
Mar 01, 2024
FDA denies petition for qualified health claim for D-tagatose and reduced risk of type II diabetes
USA
Feb 27, 2024
FSANZ revises the use of 2-fucosyl lactose produced by GM Corynebacterium glutamicum in infant formula
Australia
Feb 23, 2024
UK - The Prevalence and Compliance of Health Claims Used in the Labelling and Information for Prepacked Foods within Great Britain
UK
Feb 07, 2024
SFA proposes to extend use of additives in infant formula
Singapore
Feb 07, 2024
FDA amends health claims regulation
Thailand
Jan 24, 2024
SAMR to require registration of liquid infant formula
China
Jan 24, 2024
Parliament Implementation report on Regulation (EC) No 1924/2006 (nutrition and health claims)
European Union
Jan 22, 2024
